MedTrace Logo

Medication Adherence and "True" Resistance in Patients With Resistant Hypertension

NCT02128386 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-02-23

No results posted yet for this study

Summary

The purpose of this study is to estimate the proportion of patients with "true" resistance among patients referred to the Medical Outpatient Department of the Charité - Universitätsmedizin Berlin with the diagnosis "resistant hypertension". Moreover, data on medication adherence will be collected based on therapeutic drug monitoring and on the answers to validated questionnaires. Finally, efficacy, safety and costs of renal sympathetic denervation will be compared to an intensified drug treatment in an exploratory way.

Conditions

  • Hypertensive Disease
  • Hypertension, Resistant to Conventional Therapy

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Jürgen Scholze, Professor · Charite - Universitätsmedizin Berlin

  • Reinhold Kreutz, Professor · Charite University, Berlin, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-03-31
Completion
2016-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02128386 on ClinicalTrials.gov